摘要
目的:对比研究胰腺炎患者采用静脉点滴及微量输液泵应用奥曲肽治疗的临床效果差异。方法:选取笔者所在医院2018年4月-2019年4月收治的84例胰腺炎患者为试验对象,采用数字标注法分为对照组及试验组,每组42例。两组均应用奥曲肽治疗,其中对照组采用静脉点滴方式给药,试验组采用微量输液泵方式给药,比较两组临床效果和不良反应情况。结果:治疗前两组血淀粉酶、C反应蛋白、WBC计数比较差异无统计学意义(P>0.05);治疗后试验组各项指标均低于对照组,差异均有统计学意义(P<0.05)。试验组临床总有效率为97.62%,高于对照组的85.71%(P<0.05)。试验组不良反应发生率为4.76%,低于对照组的19.05%(P<0.05)。结论:胰腺炎患者应用奥曲肽治疗时,与静脉点滴方式给药相比较,以微量输液泵方式给药不仅能提升临床疗效,还有助于减少不良反应,确保患者的用药安全性,值得临床中普及应用。
Objective: To compare the clinical effects of Octreotide in patients with pancreatitis treated with intravenous drip and microinfusion pump. Method: Eighty-four patients with pancreatitis admitted to our hospital from April 2018 to April 2019 were enrolled in the study. They were divided into the control group and the experimental group by digital labeling, with 42 cases in each group. Both groups were treated with Octreotide. The control group was administered intravenously. The experimental group was administered by microinfusion pump. The clinical effects and adverse reactions of the two groups were compared. Result: There was no significant difference in serum amylase, C-reactive protein and WBC count between the two groups before treatment, but the indexes in the experimental group were lower than those in the control group after treatment, and the difference was statistically significant (P<0.05). The total clinical effective rate of the experimental group was 97.62%, which was higher than 85.71% of the control group, the difference was statistically significant (P<0.05). The incidence of adverse reactions in the experimental group was 4.76%, which was lower than 19.05% in the control group, the difference was statistically significant (P<0.05). Conclusion: In patients with pancreatitis treated with Octreotide, compared with intravenous drip administration, administration with microinfusion pump can not only improve clinical efficacy, but also help reduce adverse reactions and ensure patient safety. It is worthy of clinical practice and universal application.
作者
刘晓勇
LIU Xiaoyong(Zhongxiang People’s Hospital, Zhongxiang 431911, China)
出处
《中外医学研究》
2019年第28期147-149,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
胰腺炎
静脉点滴
微量输液泵
奥曲肽
Pancreatitis
Venous drip
Microinfusion pump
Octreotide
